SynthesisJournal of human hypertension2018

First-line renin-angiotensin system inhibitors vs. other first-line antihypertensive drug classes in hypertensive patients with type 2 diabetes mellitus.

Ganmi Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.